Biohaven’s valuation has dropped from $3.9B to $1.42B, but no revenue and high cash burn still limit its appeal. Read why BHVN stock is a hold.

Biohaven Ltd. (NYSE:BHVN) is one of the best low priced pharma stocks to buy now. Earlier on June 10, Bexorg Inc., which is a techbio company focused on central nervous system/CNS disorders ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BIOHAVEN LTD. (BHVN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.

THE LAWSUIT: A class action securities lawsuit was filed against Biohaven Ltd. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between March 24, ...

SAN DIEGO, July 16, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN ...

NEW YORK, July 16, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Biohaven Ltd ...

Therein, Biohaven disclosed that recent data from a late-stage study of BHV-7000 in bipolar mania“did not statistically separate from the comparator on the Young Mania Rating Scale primary ...

Therein, Biohaven disclosed that recent data from a late-stage study of BHV-7000 in bipolar mania “did not statistically separate from the comparator on the Young Mania Rating Scale primary ...

NEW YORK, July 16, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Biohaven Ltd ...